Form 4: RadNet Executive Norman Hames Acquires Shares and Options Following RSU Vesting

Norman Hames, President and COO-West Operations of RadNet, Inc., reports acquisition of shares and options due to performance-based vesting of restricted stock units and stock options.

Summary

• On March 4, 2024, Norman R Hames, President and COO-West Operations of RadNet, Inc., filed a Form 4.
• The filing reports transactions related to the vesting of restricted stock units (RSUs) and stock options granted on January 3, 2023.
• Due to RadNet's fiscal year 2023 performance, 200% of the target number of RSUs (originally 8,717) vested, resulting in the acquisition of 17,434 shares.
• Additionally, 100% of the shares subject to a stock option to purchase 33,789 shares vested due to performance.
• The vested RSUs will be settled for RDNT shares on the earlier of separation from service, death or disability, a change in control, or a future deferral election date.
• The vested option shares will vest as to the time-based vesting requirements in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, respectively.
• Following the reported transactions, Hames beneficially owns 295,919 shares of common stock and 33,789 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: The document indicates positive performance leading to RSU vesting, which is generally a good sign. However, it's a routine filing and doesn't contain groundbreaking news.

Positives

• The vesting of RSUs at 200% indicates strong performance by RadNet in fiscal year 2023.
• The executive's increased stake in the company aligns his interests with those of shareholders.

Future Outlook

The vested RSUs will be settled for RDNT shares on the earlier of separation from service, death or disability, a change in control, or a future deferral election date. The vested option shares will vest as to the time-based vesting requirements in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, respectively.

Industry Context

Executive compensation through stock options and RSUs is a common practice in the healthcare industry to align management's interests with shareholder value. The vesting of these instruments based on performance metrics is also a standard practice.

Comparison to Industry Standards

• RadNet's executive compensation practices, including the use of RSUs and stock options with performance-based vesting, are consistent with industry standards.
• Companies like HCA Healthcare and Tenet Healthcare also utilize similar compensation structures to incentivize their executives.
• The specific vesting percentages and performance metrics vary across companies, but the underlying principle of aligning executive compensation with company performance remains the same.

Stakeholder Impact

• Shareholders may view the vesting of RSUs and stock options as a positive sign, indicating that management is incentivized to improve company performance.
• Employees may be motivated by the company's strong performance, which led to the vesting of performance-based compensation.

Next Steps

• The vested RSUs will be settled for RDNT shares at a future date.
• The vested option shares will vest as to the time-based vesting requirements in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, respectively.

Key Dates